Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Invitae Corp.

Headquarters: San Francisco, CA, United States of America
Website: N/A
Year Founded: 2012
Status: Out of Business

BioCentury | Aug 15, 2024
Management Tracks

CFO Kemula leaving CureVac

Plus: Chemify hires CBO to realize commercial ambitions and more from Biocartis and Estrella
BioCentury | Oct 21, 2023
Management Tracks

Daly to succeed McEnany as Catalyst CEO 

Plus: Hennemand joins Covant as CEO and updates from Invitae, Immunome, Antiva, Omeros, Actimed and RegCell 
BioCentury | Oct 5, 2023
Regulation

Oct. 4 Quick Takes: FDA’s ODAC backs US WorldMeds’ eflornithine for neuroblastoma

Plus: ClavystBio launches space for start-ups in Singapore and updates from Novavax, Iambic, Sandoz, Shorla and more
BioCentury | Sep 27, 2023
Management Tracks

Syncona-backed Forcefield names Novartis vet Tsai CEO

Plus: PureTech hires Arix CEO Lyne and updates from InterVenn, Veracyte, Arcutis, Strata, Sanotize, Caribou, Mati
BioCentury | Sep 27, 2023
Management Tracks

Morphic CEO Tipirneni taking medical leave of absence

Plus: David Stack to retire as chair, CEO of Pacira and updates from AM-Pharma, Invitae, Syneos and Faeth 
BioCentury | Aug 29, 2023
Management Tracks

Crossover-backed Arbor names Tamboli CFO

Plus: Atkinson named chief technical operations officer at Vertex, and updates from Confo, Flagship, Citryll and more
BioCentury | Aug 28, 2023
Management Tracks

Kurt Graves takes top spot at i2o

Plus: Lourie Zak becomes CFO at Genelux, and updates from Delve Bio, Leo, and Synthetica
BioCentury | Aug 15, 2023
Management Tracks

Alltrna appoints new CSO, CTO

Plus: Invitae names Dickey interim CFO and an update from Ncardia
BioCentury | May 26, 2023
Management Tracks

Wen leaving Invitae as CFO

Plus: Fenton succeeds CEO Requadt at Talaris, and an update from Sera
BioCentury | May 23, 2023
Management Tracks

Obsidian fills CEO, CDO roles with Iovance vets

Plus: Jami Rubin joins Arch, and updates from Exo, Harbinger, Twist and more
Items per page:
1 - 10 of 54